Yestar Healthcare Holdings Company Limited provided unaudited consolidated earnings guidance for the six months ended 30 June 2023. For this period, the company expects to record an unaudited consolidated net profit of the Group of not less than RMB 11.6 million and an unaudited consolidated net profit attributable to the owners of the parent of not less than RMB 3.6 million for the six months ended 30 June 2023 as compared to an unaudited consolidated net loss of the Group of approximately RMB 184.1 million and an unaudited consolidated net loss attributable to the owners of the parent of approximately RMB 165.3 million for the six months ended 30 June 2022.
Yestar Healthcare Holdings Company Limited
Equities
2393
KYG9843W1125
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.044 HKD | -2.22% | -4.35% | -2.22% |
Apr. 26 | Yestar Healthcare Narrows Loss in 2023 | MT |
Apr. 09 | Yestar Healthcare Faces Second Arbitration Related to Trading Firm Acquisition | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.22% | 13.11M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- 2393 Stock
- News Yestar Healthcare Holdings Company Limited
- Yestar Healthcare Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023